Pete Feldman
Chief Executive Officer at Oncovalent Therapeutics, Inc.
Network origin in Pete Feldman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Oncovalent Therapeutics, Inc.
 Oncovalent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncovalent Therapeutics, Inc. develops immuno oncology drugs and therapeutics. The company is based in Thousand Oaks, CA. Pete Feldman has been the CEO of the company since 2020.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Pete Feldman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| EPIZYME, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| Weill Cornell Medicine | College/University | Corporate Officer/Principal |
Statistics
International
| United States | 6 |
| United Kingdom | 3 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Government | 2 |
Operational
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 2 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Giordano | 9 |
- Stock Market
- Insiders
- Pete Feldman
- Company connections
